Advance Search
Volume 38 Issue 5
May  2022
Turn off MathJax
Article Contents
LI Ya-fei, FAN Wei, WANG Wen-hua, et.al, . A school cluster outbreak of COVID-19 caused by SARS-CoV-2 Omicron variant[J]. Chinese Journal of Public Health, 2022, 38(5): 614-618. doi: 10.11847/zgggws1138512
Citation: LI Ya-fei, FAN Wei, WANG Wen-hua, et.al, . A school cluster outbreak of COVID-19 caused by SARS-CoV-2 Omicron variant[J]. Chinese Journal of Public Health, 2022, 38(5): 614-618. doi: 10.11847/zgggws1138512

A school cluster outbreak of COVID-19 caused by SARS-CoV-2 Omicron variant

doi: 10.11847/zgggws1138512
  • Received Date: 2022-03-14
    Available Online: 2022-03-19
  • Publish Date: 2022-05-20
  •   Objective  To analyze a cluster outbreak of coronavirus disease 2019 (COVID-19) caused by the Omicron variant of severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) in a boarding school for providing a reference to COVID-19 epidemic prevention and control.   Methods  From China Information System for Disease Control and Prevention, we extracted the information on all COVID-19 cases laboratory-confirmed during January 8 – 19, 2022 among the students and teachers in a boarding school at a county in Henan province. Incidence rate (proportion) and histogram were used to describe epidemiological characteristics of the outbreaks. Basic reproduction number (R0) and time-varying reproduction number (Rt) were calculated with R software.   Results  Totally 283 COVID-19 cases infected with SARS-CoV-2 Omicron BA.1 variant were diagnosed during the 12-day period and the attack rate was 6.8% for the 4 124 students and teachers of the school. The cases occurred in 23 classes (all for senior high school students and only one for junior high school students) and the class-specific attack rate ranged 1.6% – 76.8%. For the 269 student cases at a mean age of 17.0 ± 0.9 years, the male to female ratio was 1 : 1.09; while the mean age was 24.0 (25th percentile = 23.0, 75th percentile = 30.0) years for the 14 teacher cases. The estimated R0 was 5.46 (95% confidence interval: 3.11, 8.77); the estimated Rt increased first and then declined. Obvious symptoms were observed among 18.4% (52) of all cases and major clinical manifestations included fever, sore throat and cough, which occurred in 69.2%, 30.8% and 19.2% of the 52 sufferers. The confirmed cases were clinically classified as common or mild type patients.   Conclusion  The Omicron variant of SARS-CoV-2 identified among the cases of the school cluster outbreak of COVID-19 was highly contagious but induced relatively mild clinical symptoms. Follow up studies need to be conducted among the cases of the epidemic outbreak to assess long-term adverse effects of the viral infection in the infected people.
  • loading
  • [1]
    Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa[J]. Nature, 2022,doi: 10.1038/s41586-022-04411-y.
    [2]
    Saxena SK, Kumar S, Ansari S, et al. Characterization of the novel SARS-CoV-2 Omicron (B. 1.1. 529) variant of concern and its global perspective[J]. Journal of Medical Virology, 2022, 94(4): 1738 – 1744. doi: 10.1002/jmv.27524
    [3]
    Liu JY, Chandrashekar A, Sellers D, et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 omicron[J]. Nature, 2022,doi: 10.1038/s41586-022-04465-y.
    [4]
    World Health Organization. COVID-19 Weekly epidemiological update[EB/OL].(2022 – 02 – 22).https://www.who.int/publications/m/item/weekly-epidemio-logical-update-on-covid-19---22-february-2022.
    [5]
    李文艳, 杜志成, 王莹, 等. 新型冠状病毒Delta变异株引起的广州市荔湾区本土疫情流行特征分析[J]. 中华流行病学杂志, 2021, 42(10): 1763 – 1768. doi: 10.3760/cma.j.cn112338-20210613-00472
    [6]
    Brandal LT, MacDonald E, Veneti L, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021[J]. Eurosurveillance, 2021, 26(50): 2101147. doi: 10.2807/1560-7917.ES.2021.26.50.2101147
    [7]
    Zheng J, Wang ZY, Li JM, et al. High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection[J]. The Journal of Infection, 2022,doi: 10.1016/j.jinf.2022.02.015.
    [8]
    Peacock TP, Brown JC, Zhou J, et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry[J]. bioRxiv, 2022,doi: 10.1101/2021.12.31.474653.
    [9]
    王莹, 尤心怡, 王奕婧, 等. 中国新型冠状病毒肺炎疫情基本再生数评估[J]. 中华流行病学杂志, 2020, 41(4): 476 – 479. doi: 10.3760/cma.j.cn112338-20200210-00086
    [10]
    Garrett N, Tapley A, Andriesen J, et al. High rate of asymptomatic carriage associated with variant strain omicron[J]. medRxiv, 2022,doi: 10.1101/2021.12.20.21268130.
    [11]
    Kim MK, Lee B, Choi YY, et al. Clinical characteristics of 40 patients infected with the SARS-CoV-2 omicron variant in Korea[J]. Journal of Korean Medical Science, 2022, 37(3): e31. doi: 10.3346/jkms.2022.37.e31
    [12]
    Meo SA, Meo AS, AL-Jassir FF, et al. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical charac-teristics[J]. European Review for Medical and Pharmacological Sciences, 2021, 25(24): 8012 – 8018. doi: 10.26355/eurrev_202112_27652
    [13]
    Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity and mRNA vaccine effectiveness for omicron, delta, and alpha SARS-CoV-2 variants in the United States: a prospective observa-tional study[J]. medRxiv, 2022, doi: 10.1101/2022.02.06.22270558.
    [14]
    Hui KPY, Ho JCW, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo[J]. Nature, 2022,doi: 10.1038/s41586-022-04479-6.
    [15]
    Suzuki R, Yamasoba D, Kimura I, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant[J]. Nature, 2022,doi: 10.1038/s41586-022-04462-1.
    [16]
    Christensen PA, Olsen RJ, Long SW, et al. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston, Texas[J]. The American Journal of Pathology, 2022,doi: 10.1016/j.ajpath.2022.01.007.
    [17]
    Tseng HF, Ackerson BK, Luo Y, et al. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants[J]. Nature Medicine, 2022,doi: 10.1038/s41591-022-01753-y.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article views (580) PDF downloads(166) Cited by()
    Proportional views

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return